Research

Gastrointestional (GI) cancer research trials

Mercy General Hospital is participating in the following GI cancer research trials. For more information about specific trial qualifications, click on the individual trial name below.

Adventrx 510-05
A phase III multi-center randomized clinical trial to evaluate the safety and efficacy of cofactor and 5-FU plus bevacizumab vs. leucovorin and 5-FU plus bevacizumab as initial treatment for metastatic colorectal carcinoma

For more information, contact Rhoda Pineda, BS, CCRP Research Coordinator at (916) 453-4651